Why Ultragenyx Pharmaceutical Stock Is Bouncing Back Today
While Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the company's potential as a developer of treatments for rare diseases. A firm's favorable view of Ultragenyx stock is motivating some investors to click the buy button today, helping the stock recover from its recent decline.
As of 2:51 p.m. ET, shares of Ultragenyx are up 13.2%.
Image source: Getty Images.
Source Fool.com
Ultragenyx Pharmaceutical Inc. Stock
?
0.510%
With 25 Buy predictions and not a single Sell prediction Ultragenyx Pharmaceutical Inc. is an absolute favorite of our community.
With a target price of 57 € there is potential for a 187.88% increase which would mean more than doubling the current price of 19.8 € for Ultragenyx Pharmaceutical Inc..
